Kliniske studier for KOLS i Dallas, TX
12 studier for KOLS søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RekruttererFase 3
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RekruttererFase 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RekruttererFase 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Rekrutterer
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RekruttererFase 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
RekruttererFase 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RekruttererFase 2/3
- Alina Clinical Trials, LLC., Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RekruttererFase 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
RekruttererObservasjonsstudie
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RekruttererFase 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
RekruttererObservasjonsstudie
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RekruttererFase 3
- GSK Investigational Site, Dallas
KOLS-studier i andre byer
- Philadelphia, PA23 studier
- Miami, FL18 studier
- Birmingham, AL17 studier
- Boston, MA17 studier
- Houston, TX15 studier
- Orlando, FL15 studier
- Baltimore, MD14 studier
- Chicago, IL14 studier
- Pittsburgh, PA12 studier
- New York City, NY11 studier
- Ann Arbor, MI10 studier
- Winston-Salem, NC9 studier
Andre studier i Dallas
- Brystkreft55 studier
- Ikke-småcellet lungekreft52 studier
- Metastatisk kreft42 studier
- Hjertesvikt42 studier
- Kreft (alle typer)37 studier
- Prostatakreft36 studier
- Kolorektal kreft33 studier
- Fedme30 studier
- Eggstokkreft28 studier
- Blærekreft27 studier
- Lungekreft27 studier
- Endometriekreft24 studier
Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.